← Back to Search

Homeopathic Medicine

Homeopathic Medication for Post-COVID Syndrome

Phase 3
Waitlist Available
Led By Elizabeth Rice, ND
Research Sponsored by Southwest College of Naturopathic Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4, 8 and 12 weeks
Awards & highlights

Study Summary

This study is evaluating whether a homeopathic medicine can improve fatigue and quality of life for people with post-acute COVID-19 syndrome.

Eligible Conditions
  • Post-COVID Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4, 8 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4, 8 and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fatigue Assessment Scale (FAS)
SF-36 Mental Composite Score (MCS)
SF-36 Physical Composite Score (PCS)
Secondary outcome measures
Measure Yourself Medical Outcomes Profile Symptom #1
Measure Yourself Medical Outcomes Profile Symptom #2
Patient Doctor Depth of Relationship (PDDR)
+1 more

Side effects data

From 2022 Phase 3 trial • 77 Patients • NCT05104749
3%
Urinary Tract Infection
3%
Musculoskeletal Pain
3%
Headache
3%
Upper Respiratory Tract Infection
3%
Vaccine Injury
3%
Insomnia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Homeopathic Treatment Group
Placebo Group

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Homeopathic Treatment GroupExperimental Treatment1 Intervention
Individualized homeopathic medicines on impregnated lactose pellets will be prescribed to each participant based on the totality of their physical, emotional, and mental symptoms. All medicines prescribed are listed in the Homeopathic Pharmacopoeia of the United States (HPUS) as outlined in the Food, Drug, and Cosmetics Act of 1939
Group II: Placebo GroupPlacebo Group1 Intervention
Identical lactose pellets in size, odor, and taste without the impregnated homeopathic medicines.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Homeopathic Medication
2016
Completed Phase 3
~140

Find a Location

Who is running the clinical trial?

Southwest College of Naturopathic MedicineLead Sponsor
5 Previous Clinical Trials
308 Total Patients Enrolled
Samueli Institute for Information BiologyOTHER
24 Previous Clinical Trials
2,425 Total Patients Enrolled
Elizabeth Rice, NDPrincipal InvestigatorSouthwest College of Naturopathic Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Homeopathic Treatment of Post-acute COVID-19 Syndrome
Elizabeth Rice 2021. "Homeopathic Treatment of Post-acute COVID-19 Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05104749.
~21 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top